Nano cap Aytu BioScience (NASDAQ:AYTU) inks an agreement with Singapore-based Biolidics Limited for exclusive distribution of the latter’s COVID-19 IgG/IgM Rapid Test in the U.S.
Under the terms of the deal, Aytu has committed to
buying 500K tests within one day of signing the contract and a minimum
of 1.25M tests within three months.
The test has been provisionally approved by Singapore’s Health Sciences Authority and authorized for export.
https://seekingalpha.com/news/3563582-aytu-bio-up-13-premarket-on-covidminus-19-test-distribution-deal
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.